U.S. FDA Approves PADCEV(R) plus Keytruda(R) for Certain Patients with Bladder Cancer

(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (R) (enfortumab vedotin-ejfv), a Nectin-4 directed ...
The Hearty Soul on MSN

Toddler Dies of Heart Attack After Doctor's Decimal Error Results in 10x Overdose, Lawsuit ...

A two-year-old boy arrives at the hospital with a virus and low potassium. His family expect monitoring, fluids, and a ...